Primary Ciliary Dyskinesia — Research Summary
Printed from RareWays (rareways.com.au) on 11 June 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
CircRNA-regulated programmed cell death networks in cardiomyocytes: Molecular crosstalk and therapeutic translation.
Jiang Wenhua et al. — Non-coding RNA research (1 June 2026)
https://pubmed.ncbi.nlm.nih.gov/41631272/
- 2.
A systems biology approach to programmed cell death in prostate cancer: Biomarker discovery and therapeutic potential of DL-PDMP.
Oktem Elif Kubat et al. — Computational biology and chemistry (1 June 2026)
https://pubmed.ncbi.nlm.nih.gov/41576692/
- 3.
Inertial Cavitation-based Release Estimation - ICbRE.
George Benedikt et al. — Ultrasonics (1 May 2026)
https://pubmed.ncbi.nlm.nih.gov/41481948/
- 4.
FOXE1 promotes the progression of pulp inflammation by activating PANoptosis in dental pulp cells.
Gu Fan et al. — iScience (17 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41869565/
- 5.
Deep Learning-based Monoenergetic Imaging for Calcified Coronary Stenosis Assessment at Energy-integrating Detector CT.
Chang Shaojie et al. — Radiology. Cardiothoracic imaging (1 April 2026)
https://pubmed.ncbi.nlm.nih.gov/41854396/
Clinical Trials — Australian Sites
Ask your doctor whether you or your child may be eligible for any of these trials.
- 1.
Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects
Completed — Phase 1 — ReCode Therapeutics
https://clinicaltrials.gov/study/NCT05737485
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Primary Ciliary Dyskinesia
Primary ciliary dyskinesia is a rare genetic condition caused by defective cilia function, leading to chronic respiratory infections, bronchiectasis, and fertility problems. Kartagener syndrome (with situs inversus) is a subset. It is significantly underdiagnosed. No disease-modifying therapies currently exist, but several are in trials.
Most Recent Research
Cardiovascular diseases (CVDs) represent the predominant global health burden, where dysregulated programmed cell death (PCD) mechanisms critically drive myocardial injury pathogenesis. Circular RNAs (circRNAs), characterized by covalently closed structures conferring high stability, function as pivotal regulators coordinating cardiomyocyte fate through integrated networks encompassing ferroptosis, apoptosis, pyroptosis, autophagy, and necroptosis. This review synthesizes advances in understanding circRNA-mediated PCD modulation via molecular sponging, protein interactions, and epigenetic regulation. Key insights establish context-dependent circRNA functionality and validate circRNA-based diagnostic panels for CVDs stratification with enhanced accuracy. Therapeutically, viral vector-delivered protective circRNAs demonstrate significant efficacy in ameliorating post-infarction apoptosis and improving cardiac function. We further evaluate emerging CRISPR-based editing technologies and nanoplatform delivery systems for clinical translation, positioning circRNA networks as promising theranostic targets while highlighting unresolved questions regarding pathway crosstalk and tissue-specific delivery.
Common Questions
What is Primary Ciliary Dyskinesia?
Primary ciliary dyskinesia is a rare genetic condition caused by defective cilia function, leading to chronic respiratory infections, bronchiectasis, and fertility problems. Kartagener syndrome (with situs inversus) is a subset. It is significantly underdiagnosed. No disease-modifying therapies currently exist, but several are in trials.
How many clinical trials are available for Primary Ciliary Dyskinesia?
RareWays currently indexes 70 clinical trials for Primary Ciliary Dyskinesia, of which 21 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.
Where does the research data for Primary Ciliary Dyskinesia come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Primary Ciliary Dyskinesia.
No spam. Unsubscribe any time. Not medical advice.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.